Wogonin

汉黄芩素

Report date: 2025/03/13 13:37:22
NME

Base Information

Drug NameWogonin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-6 inhibitorsAndrogen Receptor antagonistsTumor necrosis factor α inhibitors
TargetsAndrogen ReceptorInterleukin-6Tumor necrosis factor α
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusN/A
Highest Status in ChinaN/A
Originator CompaniesHefei Cosource Medicine TechnologyShandong Buchang Pharmaceuticals Co LtdDaewoong Pharmaceutical Co Ltd +[4] 
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesChina Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG